Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -0.09% | 26.66 | 14.1% | $156.87m | |
| HZNP | Horizon Therapeutics Plc | 0.39% | 77.73 | 5.6% | $140.97m | |
| ACRS | Aclaris Therapeutics, Inc. | 1.00% | 18.22 | 4.7% | $139.55m | |
| CTLT | Catalent, Inc. | -1.20% | 116.86 | 2.1% | $104.47m | |
| BHC | Bausch Health Cos., Inc. | -0.09% | 26.66 | 0.0% | $101.20m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.74% | 168.65 | 2.4% | $87.66m | |
| ACST | Acasti Pharma, Inc. | -4.17% | 0.80 | 0.2% | $62.44m | |
| UTHR | United Therapeutics Corp. | 0.34% | 167.71 | 14.1% | $60.99m | |
| ISR | IsoRay, Inc. | -7.88% | 2.22 | 2.5% | $60.19m | |
| GWPH | GW Pharmaceuticals Plc | 2.37% | 141.70 | 6.1% | $50.90m | |
| AMRN | Amarin Corp. Plc | 3.80% | 6.55 | 1.5% | $50.78m | |
| PRGO | Perrigo Co. Plc | -0.29% | 43.30 | 6.8% | $50.66m | |
| ARGX | argenx SE | -1.37% | 310.98 | 0.0% | $50.51m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 5.10% | 1.03 | 0.2% | $44.38m | |
| SAGE | SAGE Therapeutics, Inc. | -4.21% | 88.55 | 7.6% | $42.82m |
Company Profile
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.